The Efficacy and Safety of Abelmoschus manihot for Reduction of Microalbuminuria in Patients with Type 2 Diabetes and Diabetic Nephropathy-A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Trial

被引：1
|
作者：
Yin, Jun
Chen, Si
Wei, Li
Jia, Weiping
机构：
来源：
DIABETES | 2023年 / 72卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.2337/db23-11-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial
    Daobin Zhou
    Wei Xu
    Hongbing Ma
    Chunting Zhao
    Yu Hu
    Yaozhong Zhao
    Depei Wu
    Xielan Zhao
    Yanjuan He
    Jinsong Yan
    Chunsen Wang
    Fanyi Meng
    Jie Jin
    Xiaohong Zhang
    Kang Yu
    Jianda Hu
    Yue Lv
    Investigational New Drugs, 2022, 40 : 349 - 360
  • [42] Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial
    Ma, Xinlei
    Yang, Fan
    Wu, Jinzhi
    Xu, Bei
    Jiang, Mengdi
    Sun, Yiduo
    Sun, Chuanying
    Yu, Ye
    Xu, Danyi
    Xiao, Lanlan
    Ren, Chunyun
    Chen, Chunyan
    Ye, Zi
    Liang, Junyu
    Lin, Jin
    Chen, Weiqian
    PLOS MEDICINE, 2023, 20 (06)
  • [43] Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial
    Zhou, Daobin
    Xu, Wei
    Ma, Hongbing
    Zhao, Chunting
    Hu, Yu
    Zhao, Yaozhong
    Wu, Depei
    Zhao, Xielan
    He, Yanjuan
    Yan, Jinsong
    Wang, Chunsen
    Meng, Fanyi
    Jin, Jie
    Zhang, Xiaohong
    Yu, Kang
    Hu, Jianda
    Lv, Yue
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 349 - 360
  • [44] Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: A randomized, open-label, multicenter trial
    Ballantyne, CM
    Miller, E
    Chitra, R
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1855 - 1864
  • [45] Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study)
    Lim, Soo
    Kim, Gyuri
    Kwon, Hyuk-Sang
    Park, Ie Byung
    Ahn, Kyu Jeung
    Park, Cheol-Young
    Kwon, Su Kyoung
    Kim, Hye Soon
    Park, Seok Won
    Kim, Sin Gon
    Moon, Min Kyong
    Kim, Eunsook
    Chung, Choon H.
    Won, Kyu Chang
    Park, Kang Seo
    Kim, Mikyung
    Chung, Dong Jin
    Lee, Chang Beom
    Kim, Tae Ho
    Lee, Moon-Kyu
    DIABETES, 2019, 68
  • [46] Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial
    Zhang, Xin-Yi
    Lv, Lang
    Zhou, Yu-Long
    Xie, Liang-Dong
    Xu, Qin
    Zou, Xiao-Fan
    Ding, Yan
    Tian, Jie
    Fan, Jia-Liang
    Fan, Hai-Wei
    Yang, Yi-Xi
    Ye, Xiao-Qun
    PHYTOTHERAPY RESEARCH, 2021, 35 (08) : 4401 - 4410
  • [47] Efficacy and safety of a new torque-controlled angiographic catheter in cerebral angiography: A multicenter, randomized, open-label trial
    Shin, Seung Min
    Lee, Ji Young
    Hun, Heo Nam
    Choo, Se Woong
    Jeon, Yong Pyo
    Chung, Jaewoo
    Ko, Jung Ho
    Koo, Hae-Won
    Shin, Dong Seoung
    Lee, Man Ryul
    Oh, Jae Sang
    HELIYON, 2024, 10 (15)
  • [48] Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients.: A 34-week, multicenter, open-label study
    Aguilar-Salinas, CA
    Gómez-Pérez, FJ
    Posadas-Romero, C
    Vázquez-Chávez, C
    Meaney, E
    Gulías-Herrero, A
    Guillén, LE
    Vega, AA
    Pérez, EM
    Romero-Nava, LE
    Gómez-Díaz, RA
    Salinas-Orozco, S
    Moguel, R
    Novoa, G
    ATHEROSCLEROSIS, 2000, 152 (02) : 489 - 496
  • [49] Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial
    Fan, Yujuan
    Xia, Mingfeng
    Yan, Hongmei
    Li, Xiaoying
    Chang, Xinxia
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 772 - 776
  • [50] Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial
    Maity, Nabakumar
    Ghosal, Malay Kumar
    Gupta, Anupam
    Sil, Amrita
    Chakraborty, Sushmita
    Chatterjee, Suparna
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (04) : 433 - 437
12345